GAIN THERAPEUTICS INC (GANX) Stock Earnings Estimates

USA Nasdaq NASDAQ:GANX • US36269B1052

1.62 USD
-0.14 (-7.95%)
At close: Feb 5, 2026
1.701 USD
+0.08 (+5%)
After Hours: 2/5/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GANX revenue by date.GANX revenue by date.
160K
433.33%
140K
-12.50%
55.2K
-60.57%

-100.00%
52.236M137.26M
162.77%
230.82M
68.16%
303.26M
31.38%
478.11M
57.66%
EBITDA
YoY % growth
GANX ebitda by date.GANX ebitda by date.
-13.81M
-297.98%
-17.72M
-28.31%
-22.17M
-25.11%
N/A
8.58%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GANX ebit by date.GANX ebit by date.
-13.83M
-297.41%
-17.78M
-28.56%
-22.253M
-25.16%
-22.651M
8.55%
-19.772M
2.84%
-27.658M
-39.89%
-30.88M
-11.65%
-36.133M
-17.01%
8.609M
123.83%
72.737M
744.89%
143.06M
96.68%
198.93M
39.05%
336.63M
69.22%
Operating Margin
GANX operating margin by date.GANX operating margin by date.
-8,643.75%-12,700.00%-40,313.59%N/AN/AN/AN/AN/A16.48%52.99%61.98%65.60%70.41%
EPS
YoY % growth
GANX eps by date.GANX eps by date.
-1.51-1.48
1.99%
-1.78
-20.27%
-0.98
48.31%
-0.66
28.49%
-0.72
-10.19%
-0.93
-27.89%
-1.18
-27.61%
-0.36
69.83%
-0.361.69
574.29%
3.90
130.12%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.15
-34.45%
-0.16
0.12%
-0.17
12.32%
-0.18
-22.40%
-0.21
-40.23%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-5.242M
-57.38%
-5.646M
-15.22%
-6.011M
-19.55%
-6.996M
-28.94%
-8.091M
-54.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.15
11.76%
-0.150.001.96%
Q2 2025
Q2Q % growth
-0.19
54.76%
-0.17-0.02-10.66%
Q1 2025
Q2Q % growth
-0.16
27.27%
-0.180.0212.85%
Q4 2024
Q2Q % growth
-0.11
69.44%
-0.190.0841.18%
Q3 2024
Q2Q % growth
-0.17
54.05%
-0.220.0522.48%
Q2 2024
Q2Q % growth
-0.42
32.26%
-0.20-0.22-105.88%
Q1 2024
Q2Q % growth
-0.22
48.84%
-0.300.0826.26%
Q4 2023
Q2Q % growth
-0.36
7.69%
-0.33-0.03-9.44%
Q3 2023
Q2Q % growth
-0.37
2.63%
-0.450.0818.67%
Q2 2023
Q2Q % growth
-0.62
-44.19%
-0.31-0.31-97.67%
Q1 2023
Q2Q % growth
-0.43
-53.57%
-0.40-0.03-7.18%
Q4 2022
Q2Q % growth
-0.39
-21.88%
-0.390.00-1.29%
Q3 2022
Q2Q % growth
-0.38
2.56%
-0.470.0919.01%
Q2 2022
Q2Q % growth
-0.43
-43.33%
-0.32-0.11-34.54%
Q1 2022
Q2Q % growth
-0.28
44.00%
-0.370.0925.30%
Q4 2021
Q2Q % growth
-0.32 -0.500.1835.54%
Q3 2021
Q2Q % growth
-0.39 -0.36-0.03-7.20%
Q2 2021
Q2Q % growth
-0.30 -0.310.013.57%
Q1 2021
Q2Q % growth
-0.50 -0.22-0.28-128.00%
GANX Yearly EPS VS EstimatesGANX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
25.5K-25.5K-100.00%
Q2 2024
Q2Q % growth
408K-408K-100.00%
Q1 2024
Q2Q % growth

-100.00%
30.6K-30.6K-100.00%
Q4 2023
Q2Q % growth
331.5K-331.5K-100.00%
Q3 2023
Q2Q % growth
280.296K-280.296K-100.00%
Q2 2023
Q2Q % growth

-100.00%
1.034M-1.034M-100.00%
Q1 2023
Q2Q % growth
55K
10.00%
55K%
Q4 2022
Q2Q % growth

-100.00%
12.75K-12.75K-100.00%
Q3 2022
Q2Q % growth

-100.00%
58.905K-58.905K-100.00%
Q2 2022
Q2Q % growth
100K
11.11%
27.877K72.123K258.72%
Q1 2022
Q2Q % growth
50K
400.00%
39.78K10.22K25.69%
Q4 2021
Q2Q % growth
40K 52.53K-12.53K-23.85%
Q3 2021
Q2Q % growth
30K 13.597K16.403K120.64%
Q2 2021
Q2Q % growth
90K
800.00%
90K%
Q1 2021
Q2Q % growth
10K 10K%
GANX Yearly Revenue VS EstimatesGANX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2029 2030 2031 2032 2033 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0.77%
Revenue0% 0% N/A N/A